Navigation Links
Ipsogen Launches MapQuant Dx(TM) Genomic Grade Test to Identify Breast Cancer Patients who Benefit From Chemotherapy
Date:5/30/2008

that MapQuant Dx(TM) Genomic Grade test downgrades 70% of grade 2 tumors to grade 1. This would represent about 50,000 spared chemotherapies in Europe and USA annually," said Dr. Jean-Marc Le Doussal, Director of the Breast Cancer Program at Ipsogen.

"MapQuant Dx(TM) Genomic Grade demonstrates our commitment to address clinicians' needs by translating the genomic profile of each tumor into reliable, intelligible and decisive information for pathologists, oncologists and patients," said Vincent Fert, President and CEO of Ipsogen.

About MapQuant Dx(TM) Genomic Grade

Clinical Validation

MapQuant Dx(TM) Genomic Grade measures the Genomic Grade index, a gene expression index discovered by oncology researchers at the Bordet Institute (Brussels, Belgium) and ISREC (Lausanne, Switzerland), two leading European cancer research institutes. In their seminal paper published in 2006 in the Journal of the National Cancer Institute (1), Pr. Sotiriou & colleagues showed that the grade, as measured today and since 1890 by histological examination of breast tumor sections under a microscope, could not describe the proliferation ability of 30 to 60 % of tumors. By contrast, the Genomic Grade index could capture proliferation in most tumors and showed superior prognostic and classification value over conventional grading methods. These findings have been validated in more than 1,100 patients, including a second study published last year in the Journal of Clinical Oncology (2). In 2008, 3 studies from the MD Anderson Cancer Center (MDACC) validated that high Genomic Grade index was predictive for benefit from chemotherapy (3).

Affymetrix Technology

MapQuant Dx(TM) Genomic Grade is based on Affymetrix technology. "Affymetrix is partnering with the world's leading diagnostic companies like Ipsogen to bring about new diagnostic tests that can provide more efficient and complete methods to better diagnose, classify and manage complex diseases like
'/>"/>

SOURCE Ipsogen SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
2. Smith & Nephew Endoscopy Launches New, Reusable Cannula Line for Hip Arthroscopy
3. Abbott Launches Next-Generation StarClose(R) SE Vascular Closure System
4. Shire Launches Nationwide Adult ADHD Mobile Awareness Tour
5. BioSpace Launches 6th Edition of Bio NC(TM) Hotbed Campaign
6. Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening
7. LifeQuest World Launches Immune System Boosting Supplement to the North American Market
8. ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics
9. Biocept Launches Noninvasive Prenatal Rh(D) Diagnostic at Annual ACOG Scientific Meeting
10. Better Nutrition Launches 2008 Summer Nutrition Tour
11. HC&B Healthcare Launches HC&B Digital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 According to a new market ... global orthobiologics market was valued at USD 3,754.6 million in ... 5,519.9million in 2019at a CAGR of 5.9% from 2013 to ... and above is afflicted by bone and joint disorders, and ... 2020. This has and will continue to increase the demand ...
(Date:8/29/2014)... Pittsburgh, PA (PRWEB) August 29, 2014 ... Chairman, Hub MacDonald, and colleague Koichiro Matsuda, Horiba Scientific, ... JASIS on September 5, 2014. JASIS , Asia’s ... September 3-5, 2014, in Makuhari Messe, Japan. , ... New Tools for Bioanalysis from Single Molecules to Single ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ... today reported financial results for the six months ... are expressed in Canadian dollars and presented under ... Quarter 2014 Highlights , Announced top-line ... (VA) primary endpoint for subjects enrolled in the ...
(Date:8/29/2014)... Hills, NY (PRWEB) August 29, 2014 ... Burnt Hills Veterinary Hospital are seeking candidates to participate ... dogs with osteoarthritis. The ultimate goal of this ... donor stem cells into one or two arthritically affected ... treated joints. , Candidates for the current investigational ...
Breaking Biology Technology:Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... Curb Unsafe Sex and Drug, Use are ... MEXICO CITY, Aug. 5 In a new ... on global leaders to aggressively,expand HIV prevention programs aimed ... Citing hundreds of clinical trials and,observational studies, the report ...
... Sales increase 107% over Second Quarter 2007, EMERYVILLE, ... ) today reported its financial results,for the three and ... income,of $4.5 million, or $0.08 per diluted share, for ... of $10.8 million, or $0.22 per diluted share, in ...
... - Product Revenue Increased 81 Percent; Tests Delivered Grew 69 Percent ... Year over Year - ... - Company Updates 2008 ... Call Today at 4:30 p.m. ET -, REDWOOD CITY, Calif., Aug. 5 Genomic Health,Inc. (Nasdaq: ...
Cached Biology Technology:Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV 2Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV 3Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV 4Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 2Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 3Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 4Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 5Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 6Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 7Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 8Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 9Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 10Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 2Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 3Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 4Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 5Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 6Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 7Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 8Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 9Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress 10
(Date:8/28/2014)... Protected areas conserve biodiversity and more action is needed ... areas, researchers say. , Published in PLOS ONE ... University of Exeter, used meta-analysis - combining results from ... years of research into these areas, to determine whether ... School of Biological Sciences, said protecting an area from ...
(Date:8/28/2014)... Many of the world,s most important crop-producing countries will ... the century if current trends continue, according to a ... More than one-in-ten pest types can already be found ... crops. If this spread advances at its current rate, ... countries will be overwhelmed by pests within the next ...
(Date:8/27/2014)... , Aug. 27, 2014  WaferGen Bio-systems, Inc. (NASDAQ: ... announced underwritten public offering of units of common stock ... for gross proceeds of $20 million, prior to deducting ... the Company.  The shares and warrants are immediately separable ... unit sold in the offering consists of 2,000 shares ...
Breaking Biology News(10 mins):Protected areas proven to protect biodiversity 2New study charts the global invasion of crop pests 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 3
... Spring Harbor, NY A four-year, multi-institutional effort co-led by ... publication of a landmark series of papers in the journal ... of maize ( Zea mays ). Maize, or corn, as ... of the world,s most important plants and the most valuable ...
... at Louisiana Tech University has found that a naturally ... salvinia. Giant salvinia is a noxious and invasive ... bodies of water, altering entire ecosystems. Under ideal ... in size every three days. Dr. H. Lynn ...
... WEST LAFAYETTE, Ind. - Purdue University scientists have helped identify ... wall development in maize, an effort that expands their ability ... biofuels production. The Purdue scientists, led by Nicholas Carpita, ... the 750 cell wall genes in the journal Plant ...
Cached Biology News:Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4Microorganism may provide key to combating giant salvinia throughout Louisiana 2Maize cell wall genes identified, giving boost to biofuel research 2
Umbilical cord blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Umbilical cord blood CD4+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Human peripheral blood CD56+ NK cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Yeast tRNA 50 l...
Biology Products: